Brandywine Global Investment Management, LLC Actinium Pharmaceuticals, Inc. Transaction History
Brandywine Global Investment Management, LLC
- $14.2 Billion
- Q3 2024
A detailed history of Brandywine Global Investment Management, LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 89,700 shares of ATNM stock, worth $100,464. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,700
Previous 128,200
30.03%
Holding current value
$100,464
Previous $948,000
82.28%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ATNM
# of Institutions
74Shares Held
8.31MCall Options Held
65.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY1.88MShares$2.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$1.82 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA686KShares$768,4910.0% of portfolio
-
State Street Corp Boston, MA603KShares$674,9660.0% of portfolio
-
Acadian Asset Management LLC Boston, MA454KShares$508,1370.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $28.2M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...